open access

Vol 48, No 3 (2014)
Case reports
Submitted: 2014-03-06
Get Citation

Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate

Karolina Dzieżyc1, Tomasz Litwin1, Anna Sobańska2, Anna Członkowska13
DOI: 10.1016/j.pjnns.2014.05.002
·
Neurol Neurochir Pol 2014;48(3):214-218.
Affiliations
  1. Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
  2. Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Warsaw, Poland
  3. Department of Clinical and Experimental Pharmacology, Medical University of Warsaw, Warsaw, Poland

open access

Vol 48, No 3 (2014)
Case reports
Submitted: 2014-03-06

Abstract

Wilson's disease (WD) is caused by excess of copper that leads to accumulation of copper mainly in the liver, brain and needs life-long decoppering therapy. However, overtreatment with anti-copper agents may lead to copper deficiency which may cause neurological and hematological symptoms. Copper is an important cofactor for many enzymes. This report describes three WD patients with diagnosed copper deficiency during zinc sulphate (ZS) treatment. After 5–16 years of therapy all patients developed leucopenia. Spinal cord injury was manifested in two of the patients. One of them also presented myopathy. In conclusion, copper deficiency may occur in different time after treatment onset, therefore regular copper metabolism and hematological monitoring is necessary.

Abstract

Wilson's disease (WD) is caused by excess of copper that leads to accumulation of copper mainly in the liver, brain and needs life-long decoppering therapy. However, overtreatment with anti-copper agents may lead to copper deficiency which may cause neurological and hematological symptoms. Copper is an important cofactor for many enzymes. This report describes three WD patients with diagnosed copper deficiency during zinc sulphate (ZS) treatment. After 5–16 years of therapy all patients developed leucopenia. Spinal cord injury was manifested in two of the patients. One of them also presented myopathy. In conclusion, copper deficiency may occur in different time after treatment onset, therefore regular copper metabolism and hematological monitoring is necessary.

Get Citation

Keywords

Copper deficiency, Wilson' s disease, Zinc sulphate

About this article
Title

Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 48, No 3 (2014)

Pages

214-218

Page views

390

Article views/downloads

1329

DOI

10.1016/j.pjnns.2014.05.002

Bibliographic record

Neurol Neurochir Pol 2014;48(3):214-218.

Keywords

Copper deficiency
Wilson's disease
Zinc sulphate

Authors

Karolina Dzieżyc
Tomasz Litwin
Anna Sobańska
Anna Członkowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl